Cargando…

Increased Albumin Oxidation in Cerebrospinal Fluid and Plasma from Alzheimer’s Disease Patients

BACKGROUND: Oxidative stress in the brain and peripheral systems is considered a major player in Alzheimer’s disease (AD). Albumin is the main transporter and the main extracellular antioxidant in the human body. OBJECTIVE: Here we explore for the first time the oxidation status of cerebrospinal flu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Costa, Montserrat, Horrillo, Raquel, Ortiz, Ana María, Pérez, Alba, Mestre, Anna, Ruiz, Agustín, Boada, Mercè, Grancha, Salvador
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6004933/ https://www.ncbi.nlm.nih.gov/pubmed/29782326 http://dx.doi.org/10.3233/JAD-180243

Ejemplares similares

Efficacy and Safety of Plasma Exchange with 5% Albumin to Modify Cerebrospinal Fluid and Plasma Amyloid-β Concentrations and Cognition Outcomes in Alzheimer’s Disease Patients: A Multicenter, Randomized, Controlled Clinical Trial
por: Boada, Mercè, et al.
Publicado: (2017)

Association of lysophosphatidic acids with cerebrospinal fluid biomarkers and progression to Alzheimer’s disease
por: Ahmad, Shahzad, et al.
Publicado: (2020)

Plasma exchange for Alzheimer's disease Management by Albumin Replacement (AMBAR) trial: Study design and progress
por: Boada, Mercè, et al.
Publicado: (2019)

Plasma exchange with albumin replacement and disease progression in amyotrophic lateral sclerosis: a pilot study
por: Povedano, Mónica, et al.
Publicado: (2021)

Progression of Blood-Brain Barrier Leakage in Patients with Alzheimer’s Disease as Measured with the Cerebrospinal Fluid/Plasma Albumin Ratio Over Time
por: Musaeus, Christian Sandøe, et al.
Publicado: (2023)

Plasma and cerebrospinal fluid cholesterol esterification is hampered in Alzheimer’s disease
por: Turri, Marta, et al.
Publicado: (2023)

Macular vessel density in the superficial plexus is not associated to cerebrospinal fluid core biomarkers for Alzheimer’s disease in individuals with mild cognitive impairment: The NORFACE cohort
por: Marquié, Marta, et al.
Publicado: (2023)

A randomized, controlled clinical trial of plasma exchange with albumin replacement for Alzheimer's disease: Primary results of the AMBAR Study
por: Boada, Mercè, et al.
Publicado: (2020)

The influence of insulin resistance on cerebrospinal fluid and plasma biomarkers of Alzheimer’s pathology
por: Westwood, Sarah, et al.
Publicado: (2017)

Plasma and cerebrospinal fluid nonenzymatic protein damage is sustained in Alzheimer's disease
por: Dakterzada, Farida, et al.
Publicado: (2023)

Proteogenomic analysis of human cerebrospinal fluid identifies neurologically relevant regulation and informs causal proteins for Alzheimer’s disease
por: Cruchaga, Carlos, et al.
Publicado: (2023)

Neuropsychological, neuropsychiatric, and quality‐of‐life assessments in Alzheimer's disease patients treated with plasma exchange with albumin replacement from the randomized AMBAR study
por: Boada, Mercè, et al.
Publicado: (2021)

Symptomatic and Disease-Modifying Therapy Pipeline for Alzheimer’s Disease: Towards a Personalized Polypharmacology Patient-Centered Approach
por: Morató, Xavier, et al.
Publicado: (2022)

Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease
por: Palmqvist, Sebastian, et al.
Publicado: (2019)

Altered TIMP-3 Levels in the Cerebrospinal Fluid and Plasma of Patients with Alzheimer’s Disease
por: Park, Jung Hyun, et al.
Publicado: (2022)

Effect of nitazoxanide on albendazole pharmacokinetics in cerebrospinal fluid and plasma in rats
por: Ruiz-Olmedo, María Isabel, et al.
Publicado: (2017)

Longitudinal Neuroimaging Analysis in Mild-Moderate Alzheimer’s Disease Patients Treated with Plasma Exchange with 5% Human Albumin
por: Cuberas-Borrós, Gemma, et al.
Publicado: (2017)

Increased blood-cerebrospinal fluid transfer of albumin in advanced Parkinson’s disease
por: Pisani, Valerio, et al.
Publicado: (2012)

Cerebrospinal fluid analysis in Guillain–Barré syndrome: value of albumin quotients
por: Rath, Jakob, et al.
Publicado: (2021)

Feasibility, safety, and tolerability of two modalities of plasma exchange with albumin replacement to treat elderly patients with Alzheimer's disease in the AMBAR study
por: Boada, Mercè, et al.
Publicado: (2022)

Levels of islet amyloid polypeptide in cerebrospinal fluid and plasma from patients with Alzheimer’s disease
por: Schultz, Nina, et al.
Publicado: (2019)

Assessment of Plasma and Cerebrospinal Fluid Biomarkers in Different Stages of Alzheimer’s Disease and Frontotemporal Dementia
por: Álvarez-Sánchez, Lourdes, et al.
Publicado: (2023)

Plasma‐derived FVIII/VWF complex shows higher protection against inhibitors than isolated FVIII after infusion in haemophilic patients: A translational study
por: Bravo, Maria Isabel, et al.
Publicado: (2022)

Metabolite Profiling of Alzheimer's Disease Cerebrospinal Fluid
por: Czech, Christian, et al.
Publicado: (2012)

Analysis of the Cerebrospinal Fluid Proteome in Alzheimer's Disease
por: Khoonsari, Payam Emami, et al.
Publicado: (2016)

Alzheimer disease pathology and the cerebrospinal fluid proteome
por: Dayon, Loïc, et al.
Publicado: (2018)

Cerebrospinal fluid in Alzheimer's: A precious tool
por: Parnetti, Lucilla, et al.
Publicado: (2016)

Tau oligomers in cerebrospinal fluid in Alzheimer's disease
por: Sengupta, Urmi, et al.
Publicado: (2017)

Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers
por: Jansen, Iris E., et al.
Publicado: (2022)

Time of Day Influences Concentrations of Total Protein and Albumin in Cerebrospinal Fluid in HIV
por: Kakarla, Visesha, et al.
Publicado: (2023)

The Correlation Study between Plasma Aβ Proteins and Cerebrospinal Fluid Alzheimer's Disease Biomarkers
por: Shin, Ho Sik, et al.
Publicado: (2016)

The Correlations of Plasma and Cerebrospinal Fluid Amyloid-Beta Levels with Platelet Count in Patients with Alzheimer's Disease
por: Sun, Hao-Lun, et al.
Publicado: (2018)

Direct Measurement of Cerebrospinal Fluid Production in Mice
por: Liu, Guojun, et al.
Publicado: (2020)

Neuroimaging analyses from a randomized, controlled study to evaluate plasma exchange with albumin replacement in mild-to-moderate Alzheimer’s disease: additional results from the AMBAR study
por: Cuberas-Borrós, Gemma, et al.
Publicado: (2022)

Aquaporin-4 expression in the cerebrospinal fluid in congenital human hydrocephalus
por: Castañeyra-Ruiz, Leandro, et al.
Publicado: (2013)

Protein changes in the cerebrospinal fluid of the different types of perinatal human hydrocephalus
por: Castañeyra-Perdomo, Agustin, et al.
Publicado: (2006)

Apolipoproteins and their subspecies in human cerebrospinal fluid and plasma
por: Koch, Manja, et al.
Publicado: (2017)

Elevated cerebrospinal fluid pressure in patients with Alzheimer's disease
por: Silverberg, Gerald, et al.
Publicado: (2006)

Alzheimer’s Disease: Biomarkers in the Genome, Blood, and Cerebrospinal Fluid
por: Huynh, Rose Ann, et al.
Publicado: (2017)

Cerebrospinal fluid biomarkers for Alzheimer's disease in Down syndrome
por: Dekker, Alain D., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_3pcs093ggfvk2f83uo0705j89c